Recruiting OBSERVATIONAL NCT04906356

Canadian SCAD Study

Canadian Spontaneous Coronary Artery Dissection (SCAD) Study and Genetic Sub-study (Prospective, Observational Registry With 10 Year Follow-up)

Sponsor: Cardiology Research UBC

Conditions Fibromuscular Dysplasia SCAD Spontaneous Coronary Artery Dissection

Interventions Genetic sub-study

Updated 4 times since 2021 Last updated: May 25, 2021 Started: Dec 1, 2018 Primary completion: Dec 1, 2033 Completion: Dec 1, 2033

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Fibromuscular Dysplasia and SCAD and is currently actively recruiting participants. Cardiology Research UBC leads this study, which shows 4 recorded versions since 2018 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Dec 2021 — Jul 2024 [monthly]

Recruiting
Jun 2021 — Dec 2021 [monthly]

Recruiting

First recorded

Dec 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cardiology Research UBC
John GB Mancini, MD
Karin Humphries, DSc

Data source: Cardiology Research UBC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vancouver, Canada